DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
R••••• P••••• H•••••••• I••
P•••••ceuticalsgroup grade Aoff every schedule since Sep 30, 2024sponsor unattributed
Nothing material in the last 200 days. Last change: 30 Sep 2024, $13.5M principal held by 1 lender; matures Dec 2026.
Mark path, consensus per quarter end
100¢ · 100¢ · 101¢ · 101¢ · 101¢Q3 2023 to Q3 2024
Principal held
at least $13.5M
sum of BDC pieces, a lower bound
Fair value
$13.5M
101c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
3
0 equity pieces beside them
Next maturity
Dec 13, 2026
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Sep 30, 2024
Events
3
dated, non-routine
Lender marks
each lender's own fair value over cost at Sep 30, 2024, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| T•• D••••• L•••••• V••• L•• | $13.5M | 101¢ | 0 pts |
Every BDC piece · 3 positions across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| T•• D••••• L•••••• V••• L•• | term loan lien unstated A••••••••• D••• 02/08/22 T••• L••• - 12.21% (S••• + 7.00%, 1.00% F••••) Net Assets 2.3% M• | $12.3M | $12.3M 101c | S+700 bp |
| T•• D••••• L•••••• V••• L•• | delayed draw term loan lien unstated A••••••••• D••• 02/08/22 D•••••• D••• T••• L••• - 11.87% (S••• + 7.00%, 1.00% F••••) Net A | $777,179 | $774,070 101c | S+700 bp |
| T•• D••••• L•••••• V••• L•• | revolver lien unstated A••••••••• D••• 02/08/22 R••••••• - 12.36% (S••• + 7.00%, 1.00% F••••) Net Assets 0.1% M•• | $430,570 | $428,848 100c | S+700 bp |
Capital structure as the BDCs see it
latest quarter end Sep 30, 2024
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| term loan lien unstated exited Sep 30, 2024 | at least $12.3M | 101c | S+700 bp | Dec 13, 2026 | 1 |
| delayed draw term loan lien unstated exited Sep 30, 2024 | at least $777,179 | 101c | S+700 bp | Dec 13, 2026 | 1 |
| revolver lien unstated exited Sep 30, 2024 | at least $430,570 | 100c | S+700 bp | Dec 13, 2026 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Sep 30, 2024 | 1 | $13.5M | $13.5M | 101c | 0 |
| Jun 30, 2024 | 1 | $13.3M | $13.2M | 101c | 0 |
| Mar 31, 2024 | 1 | $13.5M | $13.3M | 101c | 0 |
| Dec 31, 2023 | 1 | $13.6M | $13.3M | 100c | 0 |
All 8 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Sep 30, 2023 | 1 | $13.8M | $13.6M | 100c | 0 |
| Jun 30, 2023 | 1 | $14.0M | $13.6M | 99c | 0 |
| Mar 31, 2023 | 1 | $14B | $14B | 99c | 0 |
| Dec 31, 2022 | 1 | $14.5M | $13.8M | 98c | 0 |
What changed
- Facility left every BDC scheduleSep 30, 2024
- Facility left every BDC scheduleSep 30, 2024
- Facility left every BDC scheduleSep 30, 2024
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- RISING PHARMAderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- P•••••ceuticalsreportedas one filer wrote it